The Centers for Medicare and Medicaid Services negotiated prices for a first batch of drugs last year — something it could only do because of the Inflation Reduction Act, which passed in 2022.

The amended provisions under the Jan Vishwas (Amendment of Provisions) Act, 2023, notified by the Central Government last year for removal of stringent ... 2023 related to the Drugs and Cosmetics Act, ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list ... drug coverage $1.5 billion in out-of-pocket costs. “Last year we proved that negotiating for lower drug prices ...

The Ministry of Ayush has issued a draft notification to amend the First Schedule of the Drugs and Cosmetics Act ... system of medicine were also added to the Act, through the amendment in December, ...